Early Detection and Intervention for the Prevention of Psychosis

NACompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

September 30, 2013

Conditions
SchizophreniaBipolar DisorderDepressionPsychotic Disorders
Interventions
DRUG

aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine

Oral, daily, generally at lower than manufacturer's recommendations

BEHAVIORAL

Psychoeducational multifamily group treatment

Families and patients are educated on psychobiology of psychosis and trained in coping skills to avoid psychosis by reducing stress and optimizing social environment at home, school, work

BEHAVIORAL

Supported employment and education

Participants are provided direct assistance, guidance and ongoing support to gain employment and succeed in their educational goals.

Trial Locations (6)

11004

Zucker Hillside Hosptial, Glen Oaks

48108

Washtenaw County, Ann Arbor

95817

University of California-Davis, Imaging Research Center, Sacramento

97301

Mid-Valley Behavioral Care Network, Salem

04102

Portland Identification and Early Referral Program, Portland

87131-0001

University of New Mexico, Albuquerque

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Robert Wood Johnson Foundation

OTHER

lead

MaineHealth

OTHER